Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience
Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience is a paper indexed in PICO Portal from OpenAlex.
How many citations does Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience have?
Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience has 23 citations in the OpenAlex counts PICO Portal stores.
When was Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience published?
Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience has 2019 year in the PICO Portal index.
What is the open-access status of Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience?
Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience has closed oa status in the PICO Portal index.
What is the DOI of Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience?
The DOI for Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience is on the source record.
What is the PMID of Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience?
The PMID for Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience is on the source record.
What is the OpenAlex record for Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience?
The OpenAlex for Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience is on the source record.